Brief: Vyne Therapeutics Divests Topical Minocycline Assets

Journey Medical

13/01/2022 12:14

Jan 13 (Reuters) - Journey Medical Corp  DERM.O :
    * VYNE THERAPEUTICS DIVESTS TOPICAL MINOCYCLINE ASSETS
    * VYNE THERAPEUTICS INC - TRANSACTION INCLUDES CASH PAYMENTS OF $25 MILLION
AND
POTENTIAL MILESTONES OF UP TO $450 MILLION
    * VYNE THERAPEUTICS INC - PROCEEDS WILL BE USED TO FUND DEVELOPMENT OF
COMPANY'S
IMMUNO-INFLAMMATORY PIPELINE

Source text for Eikon:  ID:nGNX8sBXb4 
Further company coverage:  DERM.O